Mason Street Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-29,953
| Closed | -$4.23M | – | 266 |
|
|
2020
Q3 | $3.96M | Sell |
29,953
-457
| -2% | -$59.7K | 0.08% | 246 |
|
|
2020
Q2 | $3.52M | Buy |
30,410
+184
| +0.6% | +$21.2K | 0.07% | 267 |
|
|
2020
Q1 | $2.97M | Hold |
30,226
| – | – | 0.07% | 276 |
|
|
2019
Q4 | $4.39M | Buy |
30,226
+97
| +0.3% | +$13.4K | 0.08% | 237 |
|
|
2019
Q3 | $4.01M | Buy |
30,129
+45
| +0.1% | +$5.81K | 0.08% | 248 |
|
|
2019
Q2 | $3.44M | Buy |
30,084
+44
| +0.1% | +$5.15K | 0.07% | 302 |
|
|
2019
Q1 | $3.72M | Buy |
30,040
+419
| +1% | +$47.6K | 0.08% | 272 |
|
|
2018
Q4 | $2.98M | Buy |
29,621
+157
| +0.5% | +$17.7K | 0.07% | 288 |
|
|
2018
Q3 | $3.76M | Buy |
29,464
+89
| +0.3% | +$10.6K | 0.08% | 254 |
|
|
2018
Q2 | $3.18M | Buy |
29,375
+228
| +0.8% | +$24.8K | 0.07% | 300 |
|
|
2018
Q1 | $3.09M | Buy |
29,147
+98
| +0.3% | +$11.4K | 0.07% | 313 |
|
|
2017
Q4 | $3.4M | Buy |
29,049
+138
| +0.5% | +$15.6K | 0.08% | 287 |
|
|
2017
Q3 | $3.29M | Buy |
28,911
+145
| +0.5% | +$16.7K | 0.08% | 275 |
|
|
2017
Q2 | $3.59M | Buy |
28,766
+141
| +0.5% | +$16.7K | 0.09% | 240 |
|
|
2017
Q1 | $3.39M | Buy |
28,625
+403
| +1% | +$45.7K | 0.09% | 253 |
|
|
2016
Q4 | $2.83M | Buy |
28,222
+352
| +1% | +$37.7K | 0.08% | 305 |
|
|
2016
Q3 | $3.52M | Buy |
27,870
+244
| +0.9% | +$30.1K | 0.1% | 208 |
|
|
2016
Q2 | $3.23M | Buy |
27,626
+3,075
| +13% | +$348K | 0.09% | 230 |
|
|
2016
Q1 | $2.54M | Buy |
24,551
+1,518
| +7% | +$147K | 0.08% | 305 |
|
|
2015
Q4 | $2.29M | Buy |
23,033
+268
| +1% | +$26.2K | 0.07% | 328 |
|
|
2015
Q3 | $2.08M | Buy |
22,765
+165
| +0.7% | +$16.5K | 0.07% | 348 |
|
|
2015
Q2 | $2.4M | Buy |
22,600
+63
| +0.3% | +$6.97K | 0.07% | 318 |
|
|
2015
Q1 | $2.57M | Sell |
22,537
-28,526
| -56% | -$3.25M | 0.08% | 305 |
|
|
2014
Q4 | $5.62M | Sell |
51,063
-394
| -0.8% | -$41.5K | 0.04% | 507 |
|
|
2014
Q3 | $5.02M | Buy |
51,457
+145
| +0.3% | +$14.3K | 0.04% | 511 |
|
|
2014
Q2 | $5.17M | Sell |
51,312
-8,652
| -14% | -$844K | 0.04% | 514 |
|
|
2014
Q1 | $5.51M | Sell |
59,964
-5,809
| -9% | -$535K | 0.04% | 470 |
|
|
2013
Q4 | $5.95M | Buy |
65,773
+31,720
| +93% | +$2.74M | 0.05% | 436 |
|
|
2013
Q3 | $2.72M | Sell |
34,053
-5,959
| -15% | -$469K | 0.03% | 565 |
|
|
2013
Q2 | $2.91M | Buy |
+40,012
| New | +$2.99M | 0.03% | 558 |
|
Other funds holding ZBH
N
Mason Street Advisors's ZBH Position: Q4 2020 in Review
Mason Street Advisors sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 29,953 shares — an estimated $4.23M sold.
Mason Street Advisors first reported a position in ZBH in Q2 2013 and held it in 30 quarters. The position peaked at $5.95M in Q4 2013. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.
- Mason Street Advisors reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
- Mason Street Advisors sold 29,953 Zimmer Biomet shares in Q4 2020, an estimated $4.23M.
- Mason Street Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 30 quarters.
- Mason Street Advisors's Zimmer Biomet position peaked at $5.95M in Q4 2013.
- 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.
Based on Mason Street Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.